“Reimbursement Pathways for Proteomic Diagnostics” brought together physician leaders and industry experts to unpack how new multi-omic and AI-driven tests can achieve clinical adoption within today’s reimbursement landscape. The session explored practical strategies for aligning regulatory planning, evidence generation, and payer engagement to accelerate patient access to advanced diagnostics.

“Advances in Proteomics: Technology, Translation, and Clinical Impact” brought together leaders from MD Anderson, Harvard’s Wyss Institute, and the Human Proteome Organization to discuss breakthroughs in proteomics technologies, data integration, and clinical translation—highlighting how discovery advances are shaping the future of early disease detection and precision diagnostics.

The recent webinar, "NextGen Diagnostics: Democratizing Access to Advanced Screening," brought together a panel of experts to discuss the integration of cutting-edge technologies into diagnostic practices, with a strong focus on making these tools accessible to underserved populations.